1. Initial management of proliferative lupus nephritis: To cytotoxic or not to cytotoxic?

   • H. Michael Belmont

   Invited Commentary Pages: 87 - 88

2. Web alert

   • S. Louis Bridges Jr

   News Pages: 89 - 90

3. Literature alert

   • Arthur Kavanaugh

   Abstract Pages: 91 - 93

4. Clinical trials review: Crystal deposition diseases

   • Robert A. Terkeltaub

   Clinical Trials Review Pages: 97 - 100

5. Crystal-induced inflammatio and cartilage degradation

   • Geraldine M. McCarthy

   OriginalPaper Pages: 101 - 106

6. Crystal deposition and osteoarthritis

   • Nese Olmez
   • H. Ralph Schumacher Jr

   OriginalPaper Pages: 107 - 111

7. Familial and clinical aspects of calcium pyrophosphate deposition diseas

   • Antonio J. Reginato
   • Eric Tamesis
   • Patrick Netter

   OriginalPaper Pages: 112 - 120

8. New developments in the pathogenesis of articular cartilage calcification

   • George A. Karpouzas
   • Robert A. Terkeltaub

   OriginalPaper Pages: 121 - 127

9. The role of crystals in articular tissue degeneration

   • Herman S. Cheung

   OriginalPaper Pages: 128 - 131

10. The treatment of rheumatoid arthritis: A review of recent clinical trials

    • Ted Mikuls
    • Larry Moreland

    Clinical Trials Review Pages: 135 - 138

11. Animal models of rheumatoid arthritis and related inflammation

    • Bina Joe
    • Marie M. Griffiths
    • Ronald L. Wilder

    OriginalPaper Pages: 139 - 148

12. Therapy of rheumatoid arthritis: New developments and trends

    • E. William St. Clair

    OriginalPaper Pages: 149 - 156

13. Biologic therapies in rheumatoid arthritis

    • Ken J. Bulpitt

    OriginalPaper Pages: 157 - 163

14. The genetics of rheumatoid arthritis: Influences on susceptibility, severity, and treatment response

    • S. Louis Bridges Jr

    OriginalPaper Pages: 164 - 171